Our Vision & Mission
VortEdge, based in Texas, pioneering groundbreaking semiconductor-powered MedTech model. Our mission is to enable scalable and sustainable healthcare delivery that serves all communities effectively.
We aim to bolster U.S. semiconductor and AI hardware manufacturing while facilitating advancements in healthcare. Our commitment ensures that remote care reaches those who most need it, creating a healthier future.
Building the first vertically integrated MedTech platform powered by U.S. semiconductors. We are leveraging AI and field-tested insights to bring both Predictive and Prescriptive diagnostics to underserved communities, from rural America to the 3.5 billion globally without basic care.
Our approach isn't just about building hardware-it's about rethinking the infrastructure of care. Let's build a smarter, healthier, and more sustainable future together.
Our Impact Metrics
By the Numbers
Direct Impact
3.6M+ Lives Served, 2X Projected by 2030
Expanding access to essential diagnostic and healthcare solutions in rural and underserved regions worldwide.
Innovation Pipeline
Pending 10+ IP Products in Development
Spanning AI-enabled diagnostics, modular hardware systems, and scalable MedTech platforms.
Strategic Partnerships
15+ Global Collaborators
Including the U.S. Department of Commerce CHIPS Act NSTC Consortium, SEMI, academic institutions, public health organizations, and private sector leaders—working together to drive diagnostic equity and workforce development.
Industry Recognition
Direct Industry Access
Direct access to 50+ veteran AI, Edge computing, Semiconductor Engineers deployed globally. Including industry leading healthcare providers and executives.
Growth Trajectory
2X Outreach Expansion by 2027
Fueled by forward deployed teams to fine tune to each market, from FPGA-to-SoC to the engineering roadmap, and U.S.-based manufacturing pilots.
Human Impact
Thousands of Success Stories
From frontline health workers using real-time diagnostics to communities with improved maternal, elderly and chronic care outcomes.
Partners
